VITADX

VitaDX, a deep tech based in Rennes and Paris, develops and markets cancer diagnostic solutions combining artificial intelligence and image processing applied to cytology.

Founded in 2015, VitaDX develops and markets cancer diagnostic solutions that combine image analysis and artificial intelligence applied to cytology with its patented VisioCyt® technology. Its mission is to develop innovative and effective solutions that have a significant impact on healthcare systems for the benefit of the greatest number of patients. After several years of development and a prospective multicenter clinical study, its first solution, VisioCyt® Bladder, CE IVDR marked, allows for the diagnosis and monitoring of bladder cancer using a simple urine sample. Other devices are under development, including for bladder cancer screening and thyroid cancer diagnosis.